Amyloid-β Modulates Both AβPP and Tau Phosphorylation

Journal of Alzheimer's Disease

Volumn 45, Issue 2, 2015, Pages 495-507

  Oliveira, Joana M ^a   Henriques, Ana Gabriela ^a   Martins, Filipa ^a   Rebelo, Sandra ^a   Da Cruz E Silva, Odete A B ^a  

^a UNIVERSITY OF AVEIRO   (Portugal)

Author keywords

Alzheimer's disease; amyloid ; amyloid protein precursor; protein phosphatases; protein phosphorylation; tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CANTHARIDIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM CHLORIDE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; ROSCOVITINE; SERINE; TAU PROTEIN; THREONINE; AMYLOID BETA-PROTEIN (1-42); AMYLOID BETA-PROTEIN (25-35); ENZYME INHIBITOR; LITHIUM; PEPTIDE FRAGMENT; PURINE DERIVATIVE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; EMBRYO; FEMALE; HISTOPATHOLOGY; NERVE CELL CULTURE; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAT; SENILE PLAQUE; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL EMBRYO; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; NERVE CELL; PHOSPHORYLATION; PREGNANCY; TIME; WISTAR RAT;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CANTHARIDIN; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO, MAMMALIAN; ENZYME INHIBITORS; FEMALE; LITHIUM; NEURONS; OKADAIC ACID; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PREGNANCY; PURINES; RATS; RATS, WISTAR; TAU PROTEINS; TIME FACTORS;

EID: 84925347758     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-142664     Document Type: Article

References (60)

1. Buée L, Bussière T, Buée-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33, 95-130.
2. Gendron TF, Petrucelli L (2009) The role of tau in neurodegeneration. Mol Neurodegener 4, 13.
3. Wang J-Z, Xia Y-Y, Grundke-Iqbal I, Iqbal K (2013) Abnormal hyperphosphorylation of tau: Sites, regulation, and molecular mechanism of neurofibrillary degeneration. J Alzheimers Dis 33(Suppl 1), S123-S139.
4. Johnson GVW, Stoothoff WH (2004) Tau phosphorylation in neuronal cell function and dysfunction. J Cell Sci 117, 5721-5729.
5. Augustinack JC, Schneider A, Mandelkow E-M, Hyman BT (2002) Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol 103, 26-35.
6. Kopke E, Tung Y, Shaikh S, Alonso A, Iqbal K, Grundke-Iqbal I (1993) Microtubule-associated protein tau. Abnormal phosphorylation of a non- paired helical filament pool in Alzheimer disease. J Biol Chem 268, 24374-24384.
7. Amadoro G, Corsetti V, Ciotti MT, Florenzano F, Capsoni S, Amato G, Calissano P (2011) Endogenous Aβ causes cell death via early tau hyperphosphorylation. Neurobiol Aging 32, 969-990.
8. Bulbarelli A, Lonati E, Cazzaniga E, Gregori M, Masserini M (2009) Pin1 affects tau phosphorylation in response to Abeta oligomers. Mol Cell Neurosci 42, 75-80.
9. Da Cruz e Silva EF, da Cruz e Silva OAB (2003) Protein phosphorylation and APP metabolism. Neurochem Res 28, 1553-1561.
10. Oishi M, Nairn AC, Czernik AJ, Lim GS, Isohara T, Gandy SE, Greengard P, Suzuki T (1997) The cytoplasmic domain of Alzheimer's amyloid precursor protein is phosphorylated at Thr654, Ser655, and Thr668 in adult rat brain and cultured cells. Mol Med 3, 111-123.
11. Ando K, Iijima KI, Elliott JI, Kirino Y, Suzuki T (2001) Phosphorylation-dependent regulation of the interaction of amyloid precursor protein with Fe65 affects the production of beta-amyloid. J Biol Chem 276, 40353-40361.
12. Lee M-S, Kao S-C, Lemere CA, Xia W, Tseng H-C, Zhou Y, Neve R, Ahlijanian MK, Tsai L-H (2003) APP processing is regulated by cytoplasmic phosphorylation. J Cell Biol 163, 83-95.
13. Rebelo S, Vieira SI, Esselmann H, Wiltfang J, da Cruz e Silva EF, da Cruz e Silva OAB (2007) Tyrosine 687 phosphorylated Alzheimer's amyloid precursor protein is retained intracellularly and exhibits a decreased turnover rate. Neurodegener Dis 4, 78-87.
14. Rebelo S, Domingues SC, Santos M, Fardilha M, Esteves SLC, Vieira SI, Vintém APB, Wu W, da Cruz E, Silva EF, da Cruz E, Silva OAB (2013) Identification of a novel complex AßPP:Fe65:PP1 that regulates AßPP Thr668 phosphorylation levels. J Alzheimers Dis 35, 761-775.
15. Vieira SI, Rebelo S, Domingues SC, da Cruz e Silva EF, da Cruz e Silva OAB (2009) S655 phosphorylation enhances APP secretory traffic. Mol Cell Biochem 328, 145-154.
16. Vieira SI, Rebelo S, Esselmann H, Wiltfang J, Lah J, Lane R, Small SA, Gandy S, da Cruz E, Silva EF, da Cruz E, Silva OA (2010) Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener 5, 40.
17. Henriques AG, Domingues SCTS, Fardilha M, da Cruz e Silva EF, da Cruz e Silva OAB (2005) Sodium azide and 2-deoxy-D-glucose-induced cellular stress affects phosphorylation-dependent AbetaPP processing. J Alzheimers Dis 7, 201-212. discussion 255-262.
18. Chang K-A, Kim H-S, Ha T-Y, Ha J-W, Shin KY, Jeong YH, Lee J-P, Park C-H, Kim S, Baik T-K, Suh Y-H (2006) Phosphorylation of amyloid precursor protein (APP) at Thr668 regulates the nuclear translocation of the APP intracellular domain and induces neurodegeneration. Mol Cell Biol 26, 4327-4338.
19. Aplin AE, Gibb GM, Jacobsen JS, Gallo J-M, Anderton BH (2002) In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3β. J Neurochem 67, 699-707.
20. Suzuki T, Oishi M, Marshak DR, Czernik AJ, Nairn AC, Greengard P (1994) Cell cycle-dependent regulation of the phosphorylation and metabolism of the Alzheimer amyloid precursor protein. EMBO J 13, 1114-1122.
21. Iijima K, Ando K, Takeda S, Satoh Y, Seki T, Itohara S, Greengard P, Kirino Y, Nairn AC, Suzuki T (2002) Neuron-specific phosphorylation of Alzheimer's β-amyloid precursor protein by cyclin-dependent kinase 5. J Neurochem 75, 1085-1091.
22. Standen CL, Brownlees J, Grierson AJ, Kesavapany S, Lau K-F, McLoughlin DM, Miller CCJ (2009) Phosphorylation of thr668 in the cytoplasmic domain of the Alzheimer's disease amyloid precursor protein by stress-activated protein kinase 1b (Jun N-terminal kinase-3). J Neurochem 76, 316-320.
23. Ryoo S-R, Cho H-J, Lee H-W, Jeong HK, Radnaabazar C, Kim Y-S, Kim M-J, Son M-Y, Seo H, Chung S-H, Song W-J (2008) Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: Evidence for a functional link between Down syndrome and Alzheimer's disease. J Neurochem 104, 1333-1344.
24. Gong C-X, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm 112, 813-838.
25. Billingsley ML, Kincaid RL (1997) Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J 323(Pt 3), 577-591.
26. Da Cruz e Silva OAB, Fardilha M, Henriques AG, Rebelo S, Vieira S, da Cruz e Silva EF (2004) Signal transduction therapeutics: Relevance for Alzheimer's disease. J Mol Neurosci 23, 123-142.
27. Haass C, Kaether C, Thinakaran G, Sisodia S (2012) Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med 2, a006270.
28. Henriques AG, Oliveira JM, Carvalho L, da Cruz E Silva OAB (2014) Aβ influences cytoskeletal signaling cascades with consequences to Alzheimer's disease. Mol Neurobiol, doi: 10.1007/s12035-014-8913-4.
29. Reifert J, Hartung-Cranston D, Feinstein SC (2011) Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. J Biol Chem 286, 20797-20811.
30. Thornton C, Bright NJ, Sastre M, Muckett PJ, Carling D (2011) AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. Biochem J 434, 503-512.
31. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K (1993) Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci U S A 90, 7789-7793.
32. Takashima A, Honda T, Yasutake K, Michel G, Murayama O, Murayama M, Ishiguro K, Yamaguchi H (1998) Activation of tau protein kinase I/glycogen synthase kinase-3β by amyloid β peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci Res 31, 317-323.
33. Takashima A, Noguchi K, Michel G, Mercken M, Hoshi M, Ishiguro K, Imahori K (1996) Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β. Neurosci Lett 203, 33-36.
34. Zheng W-H, Bastianetto S, Mennicken F, Ma W, Kar S (2002) Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience 115, 201-211.
35. Alvarez A, Muñoz JP, Maccioni RB (2001) A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. Exp Cell Res 264, 266-274.
36. Koh S-H, Noh MY, Kim SH (2008) Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3. Brain Res 1188, 254-262.
37. Vintém APB, Henriques AG, da Cruz E, Silva OAB, da Cruz E, Silva EF (2009) PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease. Neurotoxicol Teratol 31, 85-88.
38. Town T, Zolton J, Shaffner R, Schnell B, Crescentini R, Wu Y, Zeng J, DelleDonne A, Obregon D, Tan J, Mullan M (2002) p35/Cdk5 pathway mediates soluble amyloid-beta peptide-induced tau phosphorylation in vitro. J Neurosci Res 69, 362-372.
39. Feyt C, Pierrot N, Tasiaux B, Van Hees J, Kienlen-Campard P, Courtoy PJ, Octave J-N (2007) Phosphorylation of APP695 at Thr668 decreases gamma-cleavage and extracellular Abeta. Biochem Biophys Res Commun 357, 1004-1010.
40. Henriques AG, Vieira SI, Rebelo S, Domingues SCTS, da Cruz e Silva EF, da Cruz e Silva OAB (2007) Isoform specific amyloid-beta protein precursor metabolism. J Alzheimers Dis 11, 85-95.
41. Henriques AG, Oliveira JM, Gomes B, Ruivo R, da Cruz E, Silva EF, da Cruz E, Silva OAB (2014) Complexing Aβ prevents the cellular anomalies induced by the peptide alone. J Mol Neurosci 53, 661-668.
42. Santos M, Rebelo S, Van Kleeff PJM, Kim CE, Dauer WT, Fardilha M, da Cruz E, Silva OA, da Cruz E, Silva EF (2013) The nuclear envelope protein, LAP1B, is a novel protein phosphatase 1 substrate. PLoS One 8, e76788.
43. Swingle M, Ni L, Honkanen RE (2007) Small-molecule inhibitors of ser/thr protein phosphatases: Specificity, use and common forms of abuse. Methods Mol Biol 365, 23-38.
44. Da Cruz e Silva EF, da Cruz e Silva OA, Zaia CT, Greengard P (1995) Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein. Mol Med 1, 535-541.
45. Goold RG, Gordon-Weeks PR (2001) Microtubule-associated protein 1B phosphorylation by glycogen synthase kinase 3beta is induced during PC12 cell differentiation. J Cell Sci 114, 4273-4284.
46. Sadleir KR, Vassar R (2012) Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism: Implications of CDK5 as a therapeutic target for Alzheimer disease. J Biol Chem 287, 7224-7235.
47. Muñoz-Montaño JR, Moreno FJ, Avila J, Dìaz-Nido J (1997) Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett 411, 183-188.
48. Monaco EA, Vallano M, Lou (2005) Roscovitine triggers excitotoxicity in cultured granule neurons by enhancing glutamate release. Mol Pharmacol 68, 1331-1342.
49. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65, 55-63.
50. Amador FC, Henriques AG, da Cruz E, Silva OAB, da Cruz E, Silva EF (2004) Monitoring protein phosphatase 1 isoform levels as a marker for cellular stress. Neurotoxicol Teratol 26, 387-395.
51. Rebelo S, Vieira SI, da Cruz E, Silva EF, da Cruz E, Silva OAB (2008) Monitoring "de novo" APP synthesis by taking advantage of the reversible effect of cycloheximide. Am J Alzheimers Dis Other Demen 23, 602-608.
52. Henriques AG, Vieira SI, da Cruz e Silva EF, da Cruz e Silva OAB (2009) A beta hinders nuclear targeting of AICD and Fe65 in primary neuronal cultures. J Mol Neurosci 39, 248-255.
53. Henriques AG, Vieira SI, Crespo-López ME, Guiomar de Oliveira MA, da Cruz e Silva EF, da Cruz e Silva OAB (2009) Intracellular sAPP retention in response to Abeta is mapped to cytoskeleton-associated structures. J Neurosci Res 87, 1449-1461.
54. Grace E, Rabiner C, Busciglio J (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid β: Implications for Alzheimer's disease. Neuroscience 114, 265-273.
55. Deshpande A, Mina E, Glabe C, Busciglio J (2006) Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26, 6011-6018.
56. Thornton C, Bright NJ, Sastre M, Muckett PJ, Carling D (2011) AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. Biochem J 434, 503-512.
57. Davis DR, Brion JP, Couck AM, Gallo JM, Hanger DP, Ladhani K, Lewis C, Miller CC, Rupniak T, Smith C (1995) The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and beta-amyloid in primary rat cortical neuronal cultures. Biochem J 309(Pt 3), 941-949.
58. Chung S-H (2009) Aberrant phosphorylation in the pathogenesis of Alzheimer's disease. BMB Rep 42, 467-474.
59. Kuchibhotla KV, Goldman ST, Lattarulo CR, Wu H-Y, Hyman BT, Bacskai BJ (2008) Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in 60structural and functional disruption of neuronal networks. Neuron 59, 214-225.
60. Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S (2014) Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. Neuropathol Appl Neurobiol 40, 121-135.